Skip to main content
Tech.euFundingExplorerBeta

Osivax

Osivax is a Clinical-stage biotech company

Lyon, FranceFounded 2017www.osivax.com
Total raised
€50M
€50,046,599
Funding rounds
3
Investors
4
distinct backers
Active since
2019-06
latest 2025-03

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood45
base rate 48% for Series B
  • In typical raise window
  • Down/flat last round
  • Low backer re-investment
Exit likelihood19
base rate 12% (2+ rounds)
  • 3 rounds raised
  • €30M+ raised
  • 9y since founding

Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2025-03-04Series B€9.4MMeiji Seika PharmaView deal →
2020-07-09Other€33MBpifrance,European Innovation CouncilView deal →
2019-07-01Series A€8.0MMeusinvest (Noshaq)View deal →

Similar companies

same sector or country